Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Credit agrmnt [a]
Appointed director
Monthly oper. report

ACCENTIA BIOPHARMACEUTICALS INC (ABPI) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2015 SC 13G/A KCG AMERICAS LLC reports a 13.7% stake in Accentia Biopharmaceuticals, Inc.
02/09/2015 SC 13G KCG AMERICAS LLC reports a 7% stake in Accentia Biopharmaceuticals, Inc.
11/12/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
07/15/2013 8-K Quarterly results
03/07/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/22/2013 4 ACCENTIA BIOPHARMACEUTICALS INC (10% Owner) has filed a Form 4 on BIOVEST INTERNATIONAL INC
02/22/2013 RW Form RW - Registration Withdrawal Request
02/22/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/14/2013 10-Q Quarterly Report for the period ended December 31, 2012
12/26/2012 10-K Annual Report for the period ended September 30, 2012
11/23/2012 8-K Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran...
10/26/2012 4 ODONNELL FRANCIS E JR (EXECUTIVE CHAIRMAN) has filed a Form 4 on ACCENTIA BIOPHARMACEUTICALS INC
Txns: Disposed of 500,000 shares @ $0
10/15/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
09/14/2012 4 Hasara Garrison J. (Acting CFO) has filed a Form 4 on ACCENTIA BIOPHARMACEUTICALS INC
09/14/2012 4 Calder Douglas W (VP Strategic Plan/Cap Markets) has filed a Form 4 on ACCENTIA BIOPHARMACEUTICALS INC
09/14/2012 4 Santos Carlos (Sr. VP of Prod Dev/Reg Affairs) has filed a Form 4 on ACCENTIA BIOPHARMACEUTICALS INC
09/14/2012 4 DUFFEY SAMUEL S (CEO/PRESIDENT/GENERAL COUNSEL) has filed a Form 4 on ACCENTIA BIOPHARMACEUTICALS INC
Txns: Granted 1,465,481 options to buy @ $0.15, valued at $219.8k
08/14/2012 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
08/14/2012 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
08/14/2012 10-Q Quarterly Report for the period ended June 30, 2012
08/14/2012 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "For further information, please visit: http://www.biovest.com Forward-Looking Statements: Statements in this press release that are not strictly historical in nature constitute “forward-looking statements.” Such statements include, but are not limited to, statements about Biovest and its product candidate, BiovaxID™ and any other statements relating to products, product candidates, product development programs, the FDA, the EMA, Health Canada or clinical study process including the commencement, process, or completion of clinical trials or the regulatory process. Such statements may include, without limitation, statements with respect to the Company's plans, objectives, expectations and intentions, and other statements identified by words such as “may,” “could,” “would,” “should,” “believe..."
07/11/2012 EFFECT Form EFFECT - Notice of Effectiveness
06/27/2012 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
06/21/2012 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Form of Subscription Agreement",
"Form of Common Stock Purchase Warrant"
06/07/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Secured Promissory Note, in the original principal amount of $1,500,000 payable by Accentia Biopharmaceuticals, Inc. to Pabeti, Inc",
"Common Stock Purchase Warrant, issued by Accentia Biopharmaceuticals, Inc. to Pabeti, Inc",
"Security Agreement, by Accentia Biopharmaceuticals, Inc. in favor of Pabeti, Inc",
"Amendment No. 1 to Plan Convertible Promissory Note, between Accentia Biopharmaceuticals, Inc. and Dennis Ryll"
06/04/2012 4 ACCENTIA BIOPHARMACEUTICALS INC (10% Owner) has filed a Form 4 on BIOVEST INTERNATIONAL INC
05/15/2012 10-Q Quarterly Report for the period ended March 31, 2012
05/01/2012 4 ACCENTIA BIOPHARMACEUTICALS INC (10% Owner) has filed a Form 4 on BIOVEST INTERNATIONAL INC
04/13/2012 8-K/A Form 8-K - Current report [amend]
03/15/2012 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933 [Amend]
03/09/2012 4 ACCENTIA BIOPHARMACEUTICALS INC (10% Owner) has filed a Form 4 on BIOVEST INTERNATIONAL INC
Txns: Disposed of 400,000 shares @ $0.75, valued at $300k
Disposed of 88,499 shares @ $0.34, valued at $30.1k
Disposed of 400,000 shares @ $0.75, valued at $300k
Disposed of 57,242 shares @ $0.58, valued at $33.2k
03/08/2012 8-K Submission of Matters to a Vote of Security Holders
03/02/2012 4 Santos Carlos (Chief Science Officer) has filed a Form 4 on ACCENTIA BIOPHARMACEUTICALS INC
03/02/2012 4 Calder Douglas W (VP Strategic Plan/Cap Markets) has filed a Form 4 on ACCENTIA BIOPHARMACEUTICALS INC
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy